Medtronic's stock lags peers due to growth challenges in the diabetes and hypertension markets. See why we recommend a sell ...

The pink, white and red blob of tissue quivers in a vat of clear goop about the size of a kitchen sink. Graduate students ...

How mission plus performance can lead to sustainable success.

In the latest trading session, Medtronic (MDT) closed at $90.01, marking a -0.89% move from the previous day. This change was narrower than the S&P 500's daily loss of 0.95%. Meanwhile, the Dow ...

In the closing of the recent trading day, Medtronic (MDT) stood at $91.69, denoting a +0.79% change from the preceding trading day.

The company will keep the systems on the market but is asking providers to check devices for visible cracks and return ...

Parkhill's exit came months after Medtronic, as part of a turnaround, decided to exit its unprofitable ventilator product line within its patient monitoring and respiratory interventions (PMRI ...

Medtronic is capturing demand for its cutting-edge solutions, as recent product launches emerge to drive new growth. With the stock still trading at 26% below its 2021 peak, there's a sense that ...

Medtronic (MDT) ended the recent trading session ... the company's expected earnings growth trajectory. The Medical - Products industry currently had an average PEG ratio of 2.15 as of ...

Farapulse, Boston Scientific’s pulsed field ablation product, fueled year-over-year growth of nearly 171% in the fourth ...

Medical device industry veteran brings over three decades of expertise in M&A, as well as structured research and development (“R&D”) ...